Lys33
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Ubiquitylation Site Page: > Lys33  -  SIRT6 (human)

Site Information
PPEELERkVWELARL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1881229505

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
liver cancer ( 1 ) , liver adenocarcinoma ( 1 ) , hepatocellular carcinoma ( 1 )
Relevant cell line - cell type - tissue:
BEL-7404 ( 1 ) , HCC (hepatic) ( 1 ) , Huh7 (hepatic) ( 1 ) , SK-HEP-1 (endothelial) ( 1 )

Downstream Regulation
Effects of modification on SIRT6:
protein degradation ( 1 )
Effects of modification on biological processes:
carcinogenesis, induced ( 1 )

References 

1

Du L, et al. (2021) USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization. Cancer Res 81, 3822-3834
33903120   Curated Info